Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGNT
1151
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $7.49M | 0.01% |
308,281
-17,888
| -5% | -$429K |
|
1152
Viavi Solutions
VIAV
$9.27B
| $7.46M | 0.01% |
1,131,939
-314,072
| -22% | -$2.29M |
|
|
MDRX
1153
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.43M | 0.01% |
543,375
-1,358,667
| -71% | -$18.3M |
|
1154
Selective Insurance
SIGI
$5.47B
| $7.41M | 0.01% |
264,275
-21,184
| -7% | -$589K |
|
|
PNK
1155
DELISTED
Pinnacle Entertainment Inc.
PNK
| $7.4M | 0.01% |
198,489
+161,659
| +439% | +$5.95M |
|
1156
Caleres
CAL
$441M
| $7.4M | 0.01% |
232,768
-15,075
| -6% | -$470K |
|
1157
Acacia Research
ACTG
$443M
| $7.39M | 0.01% |
843,161
-13,428
| -2% | -$138K |
|
1158
HEICO Corp
HEI
$49.2B
| $7.39M | 0.01% |
+309,426
| New | +$7.42M |
|
1159
Herc Holdings
HRI
$5.23B
| $7.36M | 0.01% |
135,467
-271,580
| -67% | -$16.8M |
|
1160
Sinclair Inc
SBGI
$1.06B
| $7.36M | 0.01% |
263,742
+210,372
| +394% | +$6.35M |
|
1161
Navient
NAVI
$892M
| $7.35M | 0.01% |
403,655
-479,079
| -54% | -$9.38M |
|
1162
Evertec
EVTC
$1.77B
| $7.34M | 0.01% |
345,479
+101,535
| +42% | +$2.23M |
|
|
NGHC
1163
DELISTED
National General Holdings Corp
NGHC
| $7.32M | 0.01% |
351,336
-7,092
| -2% | -$139K |
|
|
NRF
1164
DELISTED
NorthStar Realty Finance Corp.
NRF
| $7.3M | 0.01% |
229,623
-3,574,693
| -94% | -$129M |
|
1165
Nasdaq
NDAQ
$55.4B
| $7.29M | 0.01% |
+448,188
| New | +$7.52M |
|
1166
CALL
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $7.26M | 0.01% |
+183,300
| New | +$7.67M |
|
|
CVG
1167
DELISTED
Convergys
CVG
| $7.24M | 0.01% |
283,961
-228,654
| -45% | -$5.54M |
|
1168
Ingredion
INGR
$6.59B
| $7.23M | 0.01% |
90,595
-206,871
| -70% | -$16.6M |
|
1169
Northrop Grumman
NOC
$77.2B
| $7.23M | 0.01% |
45,577
-706,720
| -94% | -$113M |
|
|
EXAS
1170
DELISTED
Exact Sciences
EXAS
| $7.2M | 0.01% |
+242,075
| New | +$6.08M |
|
|
WBMD
1171
DELISTED
WebMD Health Corp.
WBMD
| $7.16M | 0.01% |
161,674
+52,447
| +48% | +$2.4M |
|
1172
Cadence Design Systems
CDNS
$90.2B
| $7.11M | 0.01% |
361,563
-527,851
| -59% | -$10.2M |
|
1173
Kite Realty
KRG
$5.25B
| $7.1M | 0.01% |
290,221
-20,507
| -7% | -$553K |
|
1174
Core Laboratories
CLB
$552M
| $7.07M | 0.01% |
+62,002
| New | +$7.52M |
|
|
EXAM
1175
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $7.07M | 0.01% |
180,813
+142,480
| +372% | +$5.86M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.